Hepatitis C Viral RNA Genotype 1 NS5a Drug Resistance Test Price 12000 AED
Hepatitis C Viral RNA Genotype 1 NS5a Drug Resistance Test in the UAE
Hepatitis C, a liver infection caused by the Hepatitis C virus (HCV), is a significant health concern. In the UAE, there are effective treatments available, but customizing the treatment to your specific viral variant is key to successful outcomes. The Hepatitis C Viral RNA Genotype 1 NS5a Drug Resistance Test can be an instrumental resource for you and your healthcare provider in making knowledgeable decisions about your treatment strategy.
Deciphering Hepatitis C and Treatment Progress:
HCV can progressively damage the liver, resulting in severe health issues. Thankfully, remarkable progress has been made in Hepatitis C treatment. Potent medications known as Direct-Acting Antivirals (DAAs) provide high cure rates with minimal side effects. However, different viral strains may react differently to these medications.
What is the NS5a Drug Resistance Test?
The Hepatitis C Viral RNA Genotype 1 NS5a Drug Resistance Test examines a specific region (NS5a) of the HCV genome in individuals infected with Genotype 1, the most prevalent strain worldwide. This region is involved in viral replication, and mutations in this area can influence the effectiveness of certain DAAs.
Why is the NS5a Drug Resistance Test Significant?
By detecting potential drug resistance mutations, this test assists your doctor in:
Personalized Treatment Plan: Choose the most potent DAA combination for your specific viral strain, enhancing your chances of successful treatment and cure. Shortened Treatment Duration: Understanding your resistance profile can potentially result in shorter treatment courses, reducing side effects and overall treatment load. Enhanced Treatment Outcomes: Early identification of resistance mutations allows your doctor to modify the treatment plan if needed, boosting the probability of a successful cure.
Who Should Opt for the NS5a Drug Resistance Test?
This test is generally suggested for individuals diagnosed with Hepatitis C Genotype 1, particularly those:
Who have not received treatment for Hepatitis C before. Who have not responded favorably to previous treatment efforts. With a high likelihood of having drug-resistant strains due to factors like previous organ transplants or extensive blood transfusions.
What to Anticipate During the Test?
The NS5a Drug Resistance Test typically involves a straightforward blood draw. There’s usually no special preparation necessary.
Interpreting the Results and Future Actions:
A healthcare professional will decode your test results.
Negative Result: This signifies no drug resistance mutations were found, enabling your doctor to select the most suitable DAA combination based on other considerations. Positive Result: A positive result indicates potential resistance to specific DAAs. Your doctor will discuss alternative DAA combinations or treatment approaches to counter this resistance.
Taking the Helm of Your Hepatitis C Treatment:
The NS5a Drug Resistance Test can be a formidable weapon in your battle against Hepatitis C. By comprehending your specific viral variant and potential drug resistance, you and your doctor can collaborate to devise a personalized treatment plan that optimizes your chances of a successful cure.
Welcome to DNA Labs UAE, where we offer the HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test. This test is designed to diagnose and assess the drug resistance of Hepatitis C Virus (HCV) genotype 1 NS5a.
Test Components
- HCV NS5a Subtype
- Daclatasvir Resistance
- Ledipasvir Resistance
- Ombitasvir Resistance
Price
The cost of the HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test is 12,000.0.AED
Sample Condition
For the test, we require 2 mL (1 mL) of plasma in 1 Lavender top (EDTA) tube or 2 mL (1 mL) of serum in 1 SST. Please separate the plasma/serum aseptically within 8 hours of collection and ship it refrigerated or frozen. It is mandatory to fill the Test Send Out Consent Form.
Report Delivery
The sample should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.
Method
The HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test utilizes Polymerase Chain Reaction (PCR) and Sequencing techniques.
Test Type
This test is specifically designed to diagnose and assess the drug resistance of Hepatitis C Virus (HCV) genotype 1 NS5a, which is a disease of the liver.
Doctor
This test is recommended to be performed under the supervision of a Gastroenterologist.
Test Department
The HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test is conducted in our OS department.
Pre Test Information
It is mandatory to fill the Test Send Out Consent Form before undergoing the HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test.
Test Details
The HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test is a genetic test that analyzes the exome of three individuals within a family unit. It focuses on the proband, who is affected by a genetic disorder, and both of their biological parents. By analyzing the exome, this test can identify genetic variants that may be responsible for causing a genetic disorder or increasing the risk of developing one. The test utilizes next-generation sequencing (NGS) technology to analyze millions of DNA sequences simultaneously. It can detect single nucleotide variants (SNVs), small insertions and deletions (indels), and structural variants (SVs) such as copy number variations (CNVs) and inversions. The test can also identify de novo mutations, which are genetic changes that occur spontaneously and are not inherited from either parent. The HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test is used to diagnose genetic disorders, identify carriers of genetic disorders, and assess the risk of developing certain genetic disorders. It can also provide information about the inheritance pattern of a genetic disorder, aiding in family planning and genetic counseling.
| Test Name | HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE Test |
|---|---|
| Components | *HCV NS5a Subtype*Daclatasvir Resistance *Ledipasvir resistance*Ombitasvir Resistance |
| Price | 12000.0 AED |
| Sample Condition | 2 mL (1 mL) plasma in 1 Lavender top (EDTA) tube OR2 mL (1 mL) serum in 1 SST. Separate plasma \/ serum asepticallywithin 8 hours of collection. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.\n\n\n\n. |
| Report Delivery | Sample by 7th of the month; Report after 2??3 weeks |
| Method | Polymerase Chain Reaction, Sequencing |
| Test type | Disease of Liver |
| Doctor | Gastroenterologist |
| Test Department: | OS |
| Pre Test Information | Duly filled Test Send Out Consent Formis mandatory. |
| Test Details | The NGS Gen Whole Exome Sequencing Trio Test is a genetic test that analyzes the exome of three individuals within a family unit: a proband (the individual who is affected by a genetic disorder), and both of their biological parents. The exome is the part of the genome that codes for proteins, which are the building blocks of the body. By analyzing the exome, this test can identify genetic variants that may be responsible for causing a genetic disorder or increasing the risk of developing one. The NGS Gen Whole Exome Sequencing Trio Test uses next-generation sequencing (NGS) technology to analyze millions of DNA sequences simultaneously. The test can detect single nucleotide variants (SNVs), small insertions and deletions (indels), and structural variants (SVs) such as copy number variations (CNVs) and inversions. The test can also identify de novo mutations, which are genetic changes that occur spontaneously and are not inherited from either parent. The NGS Gen Whole Exome Sequencing Trio Test is used to diagnose genetic disorders, identify carriers of genetic disorders, and assess the risk of developing certain genetic disorders. The test can also be used to provide information about the inheritance pattern of a genetic disorder, which can help with family planning and genetic counseling. |
